Why choose tiotropium for my patient? A comprehensive review of actions and outcomes versus other bronchodilators.
Author
Halpin, David M
Kaplan, A G
Russell, R K
Date
2017-07Journal
Respiratory medicineType
Journal ArticlePublisher
ElsevierDOI
10.1016/j.rmed.2017.04.008Rights
Archived with thanks to Respiratory medicineMetadata
Show full item recordAbstract
Chronic obstructive pulmonary disease (COPD) and asthma are leading causes of morbidity and mortality. This narrative review provides an appraisal of the pharmacological and clinical characteristics of tiotropium in COPD and asthma, and examines how these compare with other long-acting bronchodilators. The evidence base is placed into context by relating it to factors affecting clinicians' choice of therapy.